We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Alphatec (ATEC) Soars 7%: Is Further Upside Left in the Stock?
Read MoreHide Full Article
Alphatec (ATEC - Free Report) shares rallied 7% in the last trading session to close at $8.67. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.8% gain over the past four weeks.
Alphatec recorded a strong price rise on investors’ optimism surrounding a bullish Morgan Stanley report. Going by a PULSE 2.0 article, Morgan Stanley analyst Drew Ranieri has initiated coverage of Alphatec observing the company’s premium above-peer growth, that should continue for the foreseeable future with meaningful spine market share gains ahead.
This medical equipment and supplies holding company is expected to post quarterly loss of $0.30 per share in its upcoming report, which represents a year-over-year change of +30.2%. Revenues are expected to be $81.8 million, up 30.1% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Alphatec, the consensus EPS estimate for the quarter has been revised 8.9% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on ATEC going forward to see if this recent jump can turn into more strength down the road.
Alphatec belongs to the Zacks Medical - Instruments industry. Another stock from the same industry, 908 Devices Inc. (MASS - Free Report) , closed the last trading session 8.9% higher at $16.54. Over the past month, MASS has returned -21.1%.
908 Devices Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.22. Compared to the company's year-ago EPS, this represents a change of -15.8%. 908 Devices Inc. currently boasts a Zacks Rank of #3 (Hold).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Alphatec (ATEC) Soars 7%: Is Further Upside Left in the Stock?
Alphatec (ATEC - Free Report) shares rallied 7% in the last trading session to close at $8.67. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.8% gain over the past four weeks.
Alphatec recorded a strong price rise on investors’ optimism surrounding a bullish Morgan Stanley report. Going by a PULSE 2.0 article, Morgan Stanley analyst Drew Ranieri has initiated coverage of Alphatec observing the company’s premium above-peer growth, that should continue for the foreseeable future with meaningful spine market share gains ahead.
This medical equipment and supplies holding company is expected to post quarterly loss of $0.30 per share in its upcoming report, which represents a year-over-year change of +30.2%. Revenues are expected to be $81.8 million, up 30.1% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Alphatec, the consensus EPS estimate for the quarter has been revised 8.9% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on ATEC going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Alphatec belongs to the Zacks Medical - Instruments industry. Another stock from the same industry, 908 Devices Inc. (MASS - Free Report) , closed the last trading session 8.9% higher at $16.54. Over the past month, MASS has returned -21.1%.
908 Devices Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.22. Compared to the company's year-ago EPS, this represents a change of -15.8%. 908 Devices Inc. currently boasts a Zacks Rank of #3 (Hold).